Global analysis of differentially expressed genes in BRCA1-deficient murine ovarian cancer cell lines

被引：0
|
作者：
Lang, Jennifer
Xing, Deyin
Orsulic, Sandra
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1443
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Identification of BRCA1-deficient ovarian cancers
    Skytte, Anne-Bine
    Waldstrom, Marianne
    Rasmussen, Anders Aamann
    Cruger, Dorthe
    Woodward, Emma R.
    Kolvraa, Steen
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2011, 90 (06) : 593 - 599
  • [2] Proteomic analysis demonstrates that BRCA1-deficient epithelial ovarian cancer cell lines activate alternative pathways following exposure to cisplatin
    Lesnock, I.
    Hood, B.
    Sun, M.
    Teng, B.
    Rungruang, B.
    Flint, M.
    Krivak, T.
    Conrads, T.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S53 - S54
  • [3] The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP
    Yue, Wei
    Ma, Jihong
    Xiao, Yinan
    Wang, Pan
    Gu, Xiaoyang
    Xie, Bingteng
    Li, Mo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [4] Chemopreventive Effects of ROS Targeting in a Murine Model of BRCA1-Deficient Breast Cancer
    Li, Mo
    Chen, Qian
    Yu, Xiaochun
    CANCER RESEARCH, 2017, 77 (02) : 448 - 458
  • [5] MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland
    Wronski, A.
    Sandhu, G. K.
    Milevskiy, M. J. G.
    Brewster, B. L.
    Bridge, J. A.
    Shewan, A. M.
    Edwards, S. L.
    French, J. D.
    Brown, M. A.
    ONCOGENESIS, 2016, 5 : e218 - e218
  • [6] MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland
    A Wronski
    G K Sandhu
    M J G Milevskiy
    B L Brewster
    J A Bridge
    A M Shewan
    S L Edwards
    J D French
    M A Brown
    Oncogenesis, 2016, 5 : e218 - e218
  • [7] Getting to the Root of BRCA1-Deficient Breast Cancer
    Ginestier, Christophe
    Liu, Suling
    Wicha, Max S.
    CELL STEM CELL, 2009, 5 (03) : 229 - 230
  • [8] Mitotic catastrophe cell death induced by heat shock protein 90 inhibitor in BRCA1-deficient breast cancer cell lines
    Zajac, Magdalena
    Moneo, Maria Victoria
    Carnero, Amancio
    Benitez, Javier
    Martinez-Delgado, Beatriz
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) : 2358 - 2366
  • [9] PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
    Ding, Liya
    Kim, Hye-Jung
    Wang, Qiwei
    Kearns, Michael
    Jiang, Tao
    Ohlson, Carolynn E.
    Li, Ben B.
    Xie, Shaozhen
    Liu, Joyce F.
    Stover, Elizabeth H.
    Howitt, Brooke E.
    Bronson, Roderick T.
    Lazo, Suzan
    Roberts, Thomas M.
    Freeman, Gordon J.
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    Zhao, Jean J.
    CELL REPORTS, 2018, 25 (11): : 2972 - +
  • [10] CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer
    Higuchi, Tomoe
    Flies, Dallas B.
    Marjon, Nicole A.
    Mantia-Smaldone, Gina
    Ronner, Lukas
    Gimotty, Phyllis A.
    Adams, Sarah F.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (11) : 1257 - 1268
12345